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1 Cancer Systems Biology and Personalized Medicine
1.1 Systems Biology Is Transforming Attitudes about Cancer Biology 
When an accident occurs on a busy road during rush hour in a big city, such as Montreal or 
New York, traffic is blocked for a short time. Soon, however, drivers begin to turn around 
and use alternative roads to reach their destinations. A road map of a city is a web, a 
collection of intertwined roads that allows for identification of alternative routes. 
Increasing evidence (see Chapters 4-7) shows that, similar to roads, molecules in cells are 
also networked. This structure suggests that biochemical pathways are interconnected, 
which may allow cancer to bypass the effects of a drug. 
Traditional approaches to biological studies rely mainly on linear verbal logic and 
illustrative descriptions without mathematical explanations. These approaches are only 
satisfactory for addressing mechanisms that involve a small number of elements or short 
chains of causality. Therefore, the approaches of traditional biology are unable to capture 
and unravel elaborate webs of molecular interactions. Most diseases, including cancer, 
involve a large number and variety of elements that interact via complex networks and, 
consequently, display highly nonlinear dynamics. Therefore, simply knocking out one 
target molecule in a biochemical pathway is not sufficient for treating a disease like cancer, 
because the cells often find alternative molecular routes to escape the blockage. This is one 
reason why current drug design strategies often fail. It is increasingly believed that a 
systems perspective, rather than the current gene-centric view, could solve these problems 
and open up entirely new options for cancer treatment. 
The systems approach to biological studies combines empirical, mathematical and 
computational techniques to gain an understanding of complex biological and 
physiological phenomena. For example, hundreds of proteins might be involved in 
signaling processes that ensure proper functioning of a cell. If such a signaling network is 
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disturbed or altered, a cancer phenotype could be generated. As we discussed in Chapters 4 
and 5, systems biology helps to shed light on these complex phenomena by generating 
detailed route maps of the various kinds of cellular networks and by developing 
sophisticated mathematical, statistical and computational methods and tools to analyze 
these networks. Understanding the complex systems involved in cancer will make it 
possible to develop smarter therapeutic strategies, for example, by disrupting two or three 
key intersections in a biochemical network at the same time. These approaches could lead 
to significant advances in the treatment of cancer and help in transforming traditional 
reductionism-based approaches into unbiased systems-level approaches for drug discovery.
The birth and growth of the field of systems biology have been driven by 
technological innovation in high-throughput techniques targeted to life science 
applications. Over the past few years, high-throughput techniques, such as next generation 
genome sequencing, RNA-seq, chip-on-chip, large-scale immunoprecipitation (ChIP-seq), 
microarrays and others, have been developed and used to measure gene expression and 
gene regulatory elements to identify genes that influence some interesting phenotype on a 
genome-wide scale. These technologies have triggered a dramatic change in the style of 
biological studies from a ‘one gene model’ (i.e., focusing on the identification of individual 
genes and proteins and pinpointing their roles in the cell) to a ‘multiple gene model’ (i.e., 
the belief that molecules almost never act alone and biological entities are 'systems' - 
collections of interacting parts) and have generated many ‘large-scale biology projects’. As 
these technologies become more affordable and accessible, the implementation of large-
scale biological projects is becoming more popular and routine.   
With the emergence of systems biology, huge amounts of biological data have been 
produced and this trend is expected to continue in the future. The nature of high-throughput 
data is more comprehensive and unbiased than one-on-one biological data. This high-
throughput approach to research has greatly altered the field of cancer research. Scientists 
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have quickly realized that the combination of data management, interpretation, and our 
ability to obtain insights into these data are now the bottleneck in systems science, because 
‘real signals’ or molecular mechanisms and biological principles are buried in this flood of 
data. 
The only way to deal with large amounts of data and the relationships within those 
datasets is through mathematical representation and computation. Systems biology tends to 
meet theses challenges by integrating many types of -omic data and developing effective 
computational tools to decipher the complex systems. Network and graph theory have been 
developed to describe, analyze and model the complexity of these biological systems using 
a mathematical language. As shown in Chapters 2, 4, 6 and 8, by applying network theory 
to biological systems, we are able to transform the biological language into a mathematical 
language, which is computable and can deal with the huge number of relations in a 
biological dataset. In fact, the fundamental framework of systems biology is network 
biology, which involves the use of networks to represent complexity, compute and model 
biological relationships and seek to uncover biological principles and insights. A detailed 
discussion of network biology can be found in Chapter 2. Examples of cancer network 
studies can be found in Chapters 4-6 and 8.  
This chapter illustrates strategies, procedures and computational techniques for the 
study of cancer systems biology by focusing on network reconstruction, network analysis 
and modeling. Meanwhile, to match the contents of these strategies and procedures, I will 
guide the readers to the relevant chapters of this book. Finally, certain challenges and 
hurdles in cancer systems biology will also be discussed.
1.2 Systems Biology Is the Tool for Personalized Medicine
Recent studies have determined that many drugs work well for less than half of the patients 
for whom they are prescribed. Furthermore, nearly 3 million incorrect or ineffective 
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prescriptions are written annually and more than 100,000 people in the U.S. die each year 
from drug-related adverse events . These data strongly suggest that one-size-fits-all 
medicine and preventive care are not effective. Moreover, effective treatment of disease 
requires that the provider consider the effects of the patient’s personal genetic background. 
Personalized medicine is a proposed approach to develop treatment regimes that take into 
account each patient’s unique genetic profile, allowing the treatment to fit the specific 
needs of subpopulations of patients with different genetic backgrounds. Furthermore, this 
approach would help doctors to better evaluate the risk-to-reward scenarios and prescribe 
appropriate pharmaceuticals for different subpopulations of patients. 
Over the past decade, cancer therapy has slowly begun to change from a one-size-
fits-all approach to a more personalized approach. In a personalized approach, patients are 
treated based on the specific genetic defects present in their tumor. However, cancer is an 
extremely complex, heterogeneous disease. It is believed that crucial breakthroughs in the 
treatment of cancer, in the framework of personalized medicine, rely on the achievements 
of the powerful scientific approach of systems biology. Therefore, more efforts in ‘-omics’ 
and systems biology have been made in the cancer research community. As a result, a 
tremendous amount of money has been poured into the field of cancer research over the 
past few years. Relatively speaking, more high-throughput data have been generated in 
cancer biology than in any other field of biology. However, the complexity of cancer is a 
major obstacle preventing a comprehensive understanding of the underlying molecular 
mechanisms of tumorigenesis. To crack the cancer code, network approaches have been 
developed and applied to cellular networks of cancer. 
The examination of the entire genome of tumors (i.e., for the identification of 
cancer driver-mutating genes) and the global profiling of -omic data for cell signaling (i.e., 
gene expression, epigenetic and metabolomic profiles, and signaling data such as 
phosphoproteomic profiles) will aid in the construction of patient-specific cancer signaling 
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networks. Analysis of such tumor signaling networks could help in making individualized 
risk predictions and treatment decisions. The cost of sequencing an entire human genome is 
rapidly falling. The continual development of faster and cheaper DNA sequencing 
technologies, (for example, the next generation of DNA sequencing, which aims to decode 
a human genome for $1,000) could provide the ability to identify cancer driver-mutating 
genes in individual patients. Furthermore, profiling of tumor gene expression is also 
accessible and affordable. 
Because these data can be generated in a routine clinical manner, it is possible to 
adopt a systems biology strategy for medical research and finally move forward into the 
era of personalized medicine. For example, construction and analysis of patient-specific 
tumor signaling maps will allow for the identification of key protein communication 
modules that are critical for development of a specific tumor. Modeling and simulation of 
such a patient-specific tumor signaling map will help to infer the molecular mechanisms 
responsible for the cancer and will aid in pinpointing the key targets of the tumor. 
Furthermore, the use of computational modeling and simulation would lessen the risk of 
therapeutic failure at clinical stages. Therefore, it is predicted that network analysis and 
modeling will become a mainstream tool in both the pharmaceutical and the biotech 
industries (Figure 1).
Three major aspects of cancer biology are expected to benefit from the application 
of a systems biology approach: (1) identification of prognostic and drug-response 
biomarkers of tumors by using a systems approach to link genomic data and medical 
records, such as blood samples, lifestyle questionnaires, and patient survival (see Chapter 
4; (2) an understanding of network-oriented molecular mechanisms by building networks 
and computational models of different stages of cancer progression; (3) and an 
understanding of the network-based molecular mechanisms of metastasis and improved 
treatment of the later stages of tumors by comparative analysis of the networks of primary 
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and metastatic tumors (see Chapter 5). Finally, cancer systems biology could provide new 
insights into the network-based molecular mechanisms that cause certain drugs to fail, 
thereby helping in the selection of multiple anti-cancer drugs and optimization of treatment 
strategies.
2 Strategies for Cancer Systems Biology Study
Recent tumor genome sequencing efforts have shown that there may be thousands of 
cancer driver-mutating genes. Moreover, cancer driver-mutating genes are diverse and 
have little overlap between different tumors. This diversity is seen among different types of 
tumors and between tumors that originate from the same tissue. These observations suggest 
that cancer is a phenotype that can be caused by a collection of many genetic paths. 
However, several functional modules, the hallmarks of cancer (details of cancer hallmarks 
have been described in Chapter 12), have been uncovered and documented. In general, 
cancer driver-mutating genes reflect cancer hallmarks or functional modules. Each 
hallmark, or functional module, is composed of a set of functionally linked pathways. 
Therefore, it is possible to map the functional modules and the mutating genes onto 
network modules, each of which is a subnetwork that contains the functionally linked 
pathways on the network. For example, an integrative analysis of the human signaling 
network and cancer driver-mutating genes has revealed network modules of this type 
(details of such modules have been described in Chapter 5). 
The systems approach to cancer studies must build realistic network models of 
tumors (network construction) and identify network modules, as well as the key genes and 
other network features in each module, from these networks (network analysis and 
modeling). Ultimately, the results derived from this system biology approach must be 
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experimentally validated in cancer cell lines and mouse models. Through this approach, 
cancer systems biology enables the integration of biological and clinical data at various 
levels and has the potential to provide insight into this complex disease (Figure 1).
Network construction focuses on reconstructing functional networks that reflect the 
relationships between genes and proteins under specific conditions, such as cancer gene 
signaling networks in metastasis. These networks can encode the links between the -omic 
data and the fundamental processes of cancer development and metastasis, i.e., cancer 
hallmarks, cell cycle, apoptosis, and immunological response. Constructing a series of 
networks that incorporate time-course data may reveal the dynamics of biological 
processes such as tumor progression. Network approaches ease computational analysis, 
simplify and reduce complex interactions, and allow for the identification and 
quantification of relationships between inputs and outputs. Furthermore, network analysis 
aids in uncovering the general principles that underlie systems. To reach these goals, 
network construction relies heavily on integrative approaches to combining -omic data and 
accumulated knowledge. 
Network visualization is the process of providing tools to build intuition that is 
unsurpassed by analysis tools. These intuitions may help in forming ideas regarding 
network exploration using analytical tools. 
Network analysis focuses on computational analysis of the constructed networks 
using mathematical and statistical tools. Analysis may be performed on a single network to 
identify the important nodes, key network modules/subnetworks, and high-order relations 
between modules, such as collaboration, co-expression or co-regulation of modules. 
Furthermore, functional principles of cancer can be inferred from this type of 
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Figure 1. The strategy and procedures for cancer systems biology research.
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analysis. Therefore, hypotheses about mechanisms underlying cancer progression and 
metastasis can be generated through network analysis. Comparative analysis of time-course 
networks can highlight the dynamic nature of the functioning (or malfunctioning) of cells 
in the development and progression of diseases (i.e., cancer progression). Furthermore, 
comparative analysis can aid in the identification of key network components and their 
causal relationships during developmental stages. These analyses would capture the 
dynamic interactions between large numbers of components across different time scales, as 
well as the nonlinear nature of the systems. In addition, network analysis may lead to the 
identification of gene signatures that could be used for prognosis and drug response 
prediction through integration of gene expression or protein abundance profiles and clinical 
information about the cancer patients. 
 Network modeling involves the use of dynamic systems theory and mathematical 
tools to investigate complex biological systems in order to demonstrate nonlinear spatio-
temporal behavior. However, the generation of experimental data that are suitable to 
parameterize, calibrate and validate such models is often time-consuming and expensive, 
or even impossible, with the technology available today. Regardless, the spatiotemporal 
dynamics of the system as a whole are of such complexity that understanding those 
dynamics challenges conventional approaches and makes mathematical modeling a 
necessity.
The behavior of complex cancer cell networks cannot be deduced by intuitive 
approaches. Instead, it requires sophisticated and elegant network models and 
computational analysis and simulation. Cancer cell network models will aid in the 
generation of experimentally testable hypotheses and discovery of the underlying 
mechanisms of tumorigenesis and metastasis. Network construction may provide insights 
11
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
10
.4
32
2.
1 
: P
os
te
d 
1 
Ap
r 2
01
0
into specifying the necessary components of a biological process, a subject that is highly 
related to the explicit hypotheses of cancer development, progression and metastasis. Both 
network analysis and modeling may improve our understanding of the cancer system and 
reveal hidden patterns or counter-intuitive mechanisms in cancer, uncovering critical points 
about which our understanding is still poor. Furthermore, both analysis and modeling may 
help generate hypotheses that, in turn, can be tested in a wet lab. Finally, network analysis 
may help identify biomarkers useful in the clinical practice of personalized medicine 
(Figure 1).
2.1 Requirements for Experimental Models to Perform Cancer Systems Biology 
Before applying systems biology approaches, we should focus on the types or subtypes of 
cancer that have high clinical relevance and are well studied in terms of molecular 
pathology (i.e., pathological features can be mapped onto gene signatures). Breast cancer is 
one example of this type of cancer. Gene microarray profiles can stratify breast cancer 
samples into four subtypes . In fact, mammary epithelial cells of different origins can give 
rise to tumors with distinctly different phenotypes. Gene expression profiling of tumor 
types has shown that gene-expression changes depend on the nature of the precursor cells . 
Therefore, it is important to know the clinical subtypes of tumors when performing 
analyses. 
For a particular type or subtype of cancer, it is essential to have high quality 
experimental mouse models (i.e., progression models for different cancer stages, for 
instance prostate cancer) and a set of targeted drugs available for treatment of the cancer 
type or subtype. In general, how closely the mouse models mimic human cancer types and 
subtypes will affect the usefulness of those models in understanding the molecular 
mechanisms and guiding therapeutic decisions. Therefore, it is desirable to have mouse 
models that mirror clinical outcomes in patients with specific types of cancer. Such models 
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can be used to predict poor responses to chemotherapy in cancer patients and, therefore, 
might help in determining patient prognosis.
The selected cancer types or subtypes should have high quality cell line models that 
have been well characterized using genomic approaches. The breast cancer cell line MDA-
MB-231 is a good example of one of these models. The MDA-MB-231 line has several 
derivative lines, which display the features of organ-specific (lung, bone or brain) 
metastases .  
For experimental models, large-scale -omic data, such as genome-wide gene 
expression, phosphoproteomics, epigenetics, cancer driver-mutating genes (i.e., via tumor 
genome sequencing), and metabolomics, can be generated. To produce the best data for 
network construction, analysis and modeling, experimental biologists should interact with 
computational scientists to design experiments properly. Using this variety of data, 
construction, analysis, and modeling of tumor specific networks can be conducted. The 
networks can also be applied to mathematical frameworks for modeling and simulation.
2.2 Data Integration and Cancer Gene Network Construction
2.2.1 Cancer Gene Network Construction
The major objective of cancer systems biology is to create dynamic models of biological 
processes closely related to cancer initiation, progression and metastasis. Therefore, cancer 
networks should capture the important functional themes of cancer biology. Several 
fundamental biological processes play central roles in cancer. For example, the hallmarks 
of cancer are typical examples of these fundamental processes (detailed descriptions of 
cancer hallmarks can be read in Chapter 12). It should be noted that “new cancer 
hallmarks” might be added as understanding of cancer biology, especially cancer systems 
biology, increases. Indeed, some groups have recently proposed that inflammation may be 
a “new hallmark” for cancer . Cancer metastasis depends on both intrinsic properties of the 
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tumor cells and factors in the tumor microenvironment. These factors provide tumors with 
blood vessels and an inflammatory environment, consisting of immune cells and their 
secretory products, which promote tumor growth (the tumor microenvironment and blood 
vessels have been described in detail in Chapters 14 and 15).
Cell cycle and division, differentiation, apoptosis, angiogenesis, insensitivity to 
inhibitors (robustness), tissue invasion and metastasis (i.e., EMT, epithelial-to-
mesenchymal transition, more details about EMT have been described in Chapter 13), and 
inflammation are among the important properties of tumors. All of these processes are 
associated with cell signaling. Integrative analysis of the human signaling network with 
data about cancer driver-mutating genes suggests that cell cycle and apoptotic signaling are 
essential in all types of cancers  (Chapter 5). Most of these biological themes should be 
captured in cancer gene networks. Furthermore, the subnetworks of these themes should be 
viewed as a priority for systems biology research. Separation of these subnetworks will 
allow different cellular processes to be studied in a relatively isolated manner by network 
analysis and modeling. It should be noted that at least some of these processes are 
potentially inter-linked within the cell or the tumor microenvironment. Therefore, high-
order relationships between these processes could be modeled after a careful and 
systematic study of each individual process. 
There are three approaches for construction of cancer gene networks. The first 
approach is to infer or reverse engineer the cancer gene or signaling network using 
genome-wide datasets, such as gene expression profiles, RNAi knockout phenotype data, 
etc. For example, a gene regulatory network has been constructed using time course 
microarray profiles from a mouse epithelial breast cell line (BRI-JM01) (Wang et al. 
2007), which undergoes an epithelial to mesenchymal transition (EMT) when treated with 
TGF-β . Notably, clusterin, one of the genes that is up-regulated at the middle and late 
time-points, shows many regulatory links to other genes in the network. During the EMT 
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process, clusterin is secreted by the BRI-JM01 cells. Interestingly, application of anti-
clusterin antibodies to the TGF-β treated BRI-JM01 cells blocks the TGF-β induced EMT . 
Chapter 3 describes additional computational methods and examples of reverse engineering 
of networks.
The second network construction approach is to extend a protein interaction or 
signaling network using high-throughput experimental approaches, such as protein 
interaction measurements (Chapter 19 describes an approach for extending the human 
signaling network). This extension method also allows for the construction of gene 
regulatory networks using large-scale ChIP-seq or ChIP-on-chip data. This approach works 
especially well for the construction of gene regulatory networks. For example, the 
application of this type of approach has constructed a P53 regulatory network containing 
98 novel direct target genes of P53 . 
A cancer gene collaborative and mutually exclusive interaction network has been 
constructed by large-scale mutagenesis (i.e., retroviral insertional mutagenesis), to screen 
ARF- and P53-deficient as well as wild-type mice to identify genes that interact with one 
or the other of these tumor suppressors . For this kind of network, it should be noted that 
cancer gene collaboration has two levels: (1) a gene tends to collaborate with another gene; 
or (2) one gene may have distinct sets of collaborators, based on different mutations of that 
gene (i.e., Notch1). 
The third approach to network construction is to integrate data from high-
throughput studies or manually curated literature databases onto current networks. For 
example, current signaling networks are largely constructed using manually curated data 
from the literature . This data integration approach is widely used in network construction 
because more high-throughput data are easily accessible. Integration of high-throughput 
data through computational approaches provides a powerful method to address and dissect 
the complexity of cancer at various levels in a systems manner. Quality of data is very 
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important in the data integration approach. The decision regarding particular data sources 
used for network construction must be based on the questions to be addressed by the 
network analysis. A discussion of useful data sources for systems biology can be found in 
Chapters 16-18 and 20. 
Directly mapping genes of interest (i.e., modulated genes between normal and 
cancer tissues) onto protein interaction networks and signaling networks will lead to the 
construction of cancer related subnetworks or network modules (i.e., modulated genes are 
connected together to form a subnetwork). Several such examples are described in 
Chapters 4-7. 
Alternatively, we can map the genes of interest onto a network (i.e., a human 
signaling network) and extract all of the shortest paths between any two genes of interest. 
These shortest paths can then be merged to construct a network. The genes of interest used 
for this type of approach may be cancer-modulated genes, cancer driver-mutating genes or 
others groups. 
We can examine which shortest paths of the entire network are important for a 
particular cellular condition using functional genomics data and collect these shortest paths 
to build networks. For example, we have constructed cancer cell line-specific signaling 
networks by collecting the shortest paths that are significantly enriched in the cell line gene 
expression profile of the human signaling network. Tumor gene co-expression networks 
can be constructed using different types or subtypes of tumors. Weighted gene 
coexpression networks have been constructed using gene microarray profiles from 
glioblastoma samples . Analysis of such networks provides a blueprint for leveraging 
genomic data to identify key control networks and molecular targets in cancer. 
Cancer molecular networks can also be constructed by linking the information 
between genotypes and phenotypes. For example, Quigley and colleagues crossed mice of 
two species, Mus spretus and M. musculus, which were either resistant (Mus spretus) or 
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susceptible (M. musculus) to skin tumor development. Following the cross, they combined 
gene expression profiling with linkage analysis to construct a 'susceptibility network' of 
gene expression and regulation in the normal skin . This study highlights the power of a 
network approach for identifying genotype–phenotype relationships.
Cancer development and metastasis are dynamic processes with different 
timescales. Time series high-throughput data of cancer processes may be used to construct 
a series of networks that represent these scenarios, using the methods discussed above. To 
develop dynamic network models, we must clearly conceptualize the way time is encoded 
in networks. Analytically, time has two distinct forms: discrete and continuous. A discrete 
representation of time often consists of a series of snapshots of the network. Hence, 
longitudinal analysis focuses on the change from one network state to another. In such 
cases, a process is generally inferred from the total change in the network across time. A 
continuous representation of time consists of sequential events or interactions recorded 
with exact starting and ending times. Continuous representations of time enable the 
identification of overall network changes. However, most of the current experimental 
systems are only able to produce data for discrete representation of time in networks. 
All of the approaches discussed can be used to build tumor sample or cell line 
specific cancer networks. Construction of such networks simplifies and reduces complex 
interactions. In other words, it removes the “noisy information” from the global network 
and assembles various parts that are highly related in tumors. After constructing the cancer 
networks, it is necessary to check which cancer hallmarks have been captured. If none of 
the hallmarks can be found in the networks, it is worthwhile to check the data and network 
construction procedures. 
2.2.2 Data Integration in Systems Biology Drives New Concepts for Bioinformatics 
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Analysis
Bioinformatics provides essential tools for data integration for network construction, 
analysis and modeling. Many bioinformatics methods and tools have been developed for 
large-scale data analysis. These methods and tools include statistical tests (i.e., for testing 
gene expression differences, genetic associations and gene expression correlations), data 
extraction from literature and databases (i.e., text mining), and procedures for pattern 
recognition and machine learning (i.e., clustering analysis). 
One trend in bioinformatics analysis is the movement away from consideration of 
genes and proteins in an isolated manner. In the early days of microarray analysis, genes 
studied in gene expression profiles were examined statistically in an individual manner. 
Currently, the statistical significance of gene expression changes is assessed in a gene set-
dependent manner (i.e., taking into account pathway genes or a set of genes in a biological 
process such as cell cycle). Indeed, these methods have led to new insights into cancer 
biology. For example, alteration of the expression correlations of protein network modules 
seems to be involved in cancer metastasis. Many methods following this trend have been 
developed and used, for example the Gene Set Enrichment Analysis (GSEA). More details 
on these methods are described in Chapter 18. However, there are still many challenges in 
developing systems-oriented bioinformatics methods. For example, the problem of how to 
dissect the multivariable factors in systems, given the fact that biological variables are 
highly intertwined and correlated, remains to be solved.    
2.3 Network Visualization 
Networks represent complex systems. Although we have developed (and are continuing to 
develop) mathematical concepts and computational tools for network analysis (more details 
in next section), we are still unable to fully decode complex systems. In certain contexts, 
the human brain is still more powerful than an analytical method in forming intuitions that 
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can help guide network analysis. 
Network visualization allows us to exploit the human mind’s capacity for building 
intuition that is unsurpassed by analysis tools. Before conducting network visualization, we 
must carefully formalize questions that can be used to extract meaning and implication 
from cancer molecular networks.
The effectiveness of network visualization differs depending on network size. Thus, 
visualization has different objectives based on size. Visualization of small networks 
focuses on detailed elements of the graph structure, whereas that of larger networks mainly 
captures a more global picture. Visual analysis of small networks allows for the formation 
of insights into molecularly interacting relationships, whereas the analysis of larger 
networks allows for judgments about high-order relations (more abstractive) between 
subnetworks (i.e., interplay between network modules or components such as cell cycle 
and cell death in cancer progression). It is possible to define network modules and 
subnetworks in large networks. The intrinsic structure and relationships in each network 
module can be examined using network visualization tools. In turn, the nodes in a network 
module can be collapsed into token nodes and used to explore high-order relationships 
between modules. 
Color-coding of nodes or arcs based on molecular function, information flows or 
other related features closely related to the problems addressed, often helps in discovering 
network patterns and forming hypotheses to guide in depth analysis.
There are increasing efforts to produce network visualization beyond ‘static’ 
representations of cellular states, toward a more dynamic model of cellular processes. 
These efforts strive to incorporate high-throughput and functional data, such as time-series 
gene expression data, Gene Ontology terms and subcellular localization data. In this 
context, dynamic network visualization helps in capturing the dynamic features of a 
process, augmenting theoretical intuition and extracting meaningful patterns. 
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Two basic approaches to visualization have been developed. The first common 
visualization approach encodes all changes and transitivity between developmental stages 
(time series data) into a single network. For example, a signaling network encodes all the 
modulated genes from a time course dataset of cancer progression with different colors 
(i.e., representing different stages in cancer progression). Such a network consists of 
patterns of causal or collaborative gene relationships. However, it is necessary to identify 
the stages that substantively capture the nature of the relational events and the character of 
temporary cellular states that arise in the focal context. Changes in transitivity provide 
information about a single dimension of a network’s structure. One might find that a 
network reaches a high or low transitivity level, suggesting the potential importance of 
some stages. The clusters and information flows obtained by mixing different colorful 
nodes and links might suggest new network modules. This approach is commonly used to 
evaluate cancer progression or identify casual relationships between network modules. 
One of the most effective methods to implement dynamic network visualization is 
to present sparse networks in a way that shows how the network emerges over time (i.e., 
modulated genes in a time-series manner for cancer progression models) by adding and 
color-coding nodes and relationships as they appear (i.e., different colors can be used for 
nodes and relationships in a time-dependent manner). It is important to organize the nodes 
and edges in the display plane based on the final stage of the network. The appearance of 
dynamic elements over time reveals key genes that play roles in different stages and 
suggests regulatory relationships between network modules at different stages.   
The second common approach to network visualization is to explore separate 
networks at each time point. However, these networks are often difficult to interpret using 
pure visualization, because it is impossible to identify the sequential links between node 
positions from one network to the next. In this situation, comparative network analysis is a 
proper and powerful approach to these problems (see Section 2.4). 
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A number of network visualization tools, such as Cytoscape and VisANT, have 
been developed. VisANT has developed high-level abstraction of network relationships 
(more details about VisANT are described in Chapter 17). Chapter 20 lists many network 
visualization and analysis tools for systems biology studies. 
2.4 Network Analysis 
Genes and proteins are often used as nodes in networks, while relationships between them 
are usually represented by edges (undirected links) or arcs (directed links). A detailed 
description of network types is provided in Chapter 2 and 4. Reading Chapter 2 prior to 
this section is recommended to provide an understanding of basic concepts and terms in 
network biology. 
2.4.1 Different Biological Properties Are Encoded in Different Network Types
Although a set of common questions can be asked of cancer molecular networks, different 
questions can be addressed using different types of molecular networks, in which different 
network characteristics and relationships are encoded. Moreover, different types of data are 
necessary to construct different types of networks. 
In gene regulatory networks, the length of regulatory cascades is often short, 
normally 3-5 steps from the first layer to the last layer of the network , reflecting the quick 
regulation response of these systems. Hubs in gene regulatory networks play a major role 
in responding to stimuli and coordinating the regulated genes. In agreement with this 
mechanism, the transcripts of the hub transcription factors often display the property of 
rapid decay . Local transcription factors often encode genes that take part in one or a few 
biological processes, whereas intermediate hub transcription factors encode the 
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collaborative relationships (i.e., co-expression) between a few biological processes. The 
rapidly decaying transcripts of global hub transcription factors might encode “switch” 
functions, which are used under different conditions and stimuli. Most of the target genes 
of transcription factors are “workers,” which directly perform the tasks of biological 
processes and do not have regulatory roles. Collaborative relationships between 
transcription factors can be also found. Therefore, gene regulatory networks are useful for 
identifying key regulators, co-expression of genes, and sets of “workers” involved in 
cancer processes. 
Nodes in the human signaling network are sparsely connected. The length of 
regulatory cascades in signaling networks (normally 7-14 steps from receptors to 
transcription factors)  is often longer than the length of cascades in gene regulatory 
networks. Along these signaling cascades in protein signaling networks, almost all of the 
nodes are “regulators”. Therefore, logical regulatory relationships are extensively encoded 
in signaling networks. Cell signaling information flow propagates from a receptor to the 
nucleus. It is believed that a number of proteins scattered directly downstream of receptors 
are logical “organizers” that integrate signals. For example, hubs in signaling networks 
play a major role in integrating different signals and pathways. Therefore, signaling 
networks are useful in identifying cancer causal genes and regulatory logic involved in 
cancer processes.  
In a signaling network, paths represent signaling information flow and regulatory 
logics. In a gene regulatory network, paths represent regulatory hierarchy. In contrast, 
paths in a protein interaction network have no clear biological implications. Network paths 
also have different evolutionary features . For example, in the case of directed shortest 
paths, the more distance between two proteins, the less chance they share similar 
evolutionary rates. However, such a correlation was not observed with respect to the 
neutral shortest path. It has been shown that the evolutionary rate of proteins decreases 
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along the signaling information flow from the extracellular space (input layer) to the 
intracellular space to the nucleus (output layer) .  
The expression levels of major regulators (i.e., kinases) in signaling networks do 
not necessarily change dramatically during cancer progression and metastasis. The major 
regulatory reactions are modulated via protein modification (i.e., phosphorylation and 
dephosphorylation), not via modulation of gene expression. Therefore, direct functional 
consequences of cancer driver-mutating genes are difficult to address in gene regulatory 
networks. Most of the cancer driver-mutating genes are signaling genes. Furthermore, 
these mutating genes do not simply increase expression levels of their targets, but increase 
or decrease the activity of their targets . Monitoring the dynamics of phosphorylation and 
dephosphorylation is essential to decode signaling networks. 
Network motifs in protein interaction networks represent protein complexes, 
whereas they represent information processing units and regulatory loops in signaling and 
gene regulatory networks. In protein interaction networks, network modules represent 
protein interaction communities associated with particular biological processes, whereas in 
signaling networks, they represent blocks of regulatory logics and information processing. 
Compared to the human signaling network, nodes in the human protein interaction 
network are densely connected. Regulatory logics are difficult to identify in protein 
interaction networks. However, network modules or network communities are encoded in 
protein interaction networks. Therefore, such networks are suitable for integration of gene 
expression profiles to determine subnetworks (teams of protein ‘workers’) that perform 
certain functions at different stages of cancer development, progression and metastasis. 
Furthermore, such subnetworks could be used as biomarkers in a clinical setting.    
Generally, signaling networks are sparse and full of logical codes of regulation, 
whereas protein interaction networks are dense and do not code for logic of regulation. 
Gene regulatory networks encode both regulatory logic and gene “workers”. 
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It should be noted that post-transcriptional and post-translational regulation are 
both prevalent in cells. It is important to consider these aspects in terms of network 
construction, analysis and modeling. Ubiquitination is applicable to a wide range of human 
proteins  (see Chapter 6).  In the human signaling network, ubiquitin-mediated regulation is 
enriched in receptors and ligands, the signal initiating portion of the network . Initiated 
signals can be immediately organized and processed in the upstream region of the network, 
which resides in intracellular space close to the cell membrane. This network region is 
enriched for many built-in negative feedback loops . In contrast, MicroRNAs (miRNAs) 
regulation (negative regulation) focuses on the downstream regions of the network .    
Post- transcriptional and translational modifications of genes and their products 
provide feedback mechanisms in gene regulatory networks. miRNAs tend to post-
transcriptional regulate transcription factors. Nearly half of the human transcription factors 
are regulated by miRNAs . Furthermore, hub transcription factors tend to regulate more 
miRNAs (Chapter 7).   
2.4.2 Network Analysis Using Network Biology Methods 
Evolution is the central law of cancer cells. Similar to the laws of physics and chemistry, 
the design principles that constrain cancer biology are all amenable to discovery and 
modeling. "Core design principles" in biology must be modeled to express the mechanistic 
rules easily and efficiently. Abstraction is the most critical process required to uncover the 
design principles of biological systems. A proper abstraction aids in data examination from 
different perspectives and helps to extract meaningful knowledge from the data. Graph 
theory allows for representation of the abstraction of biological relationships, analysis of 
the information, and extraction of insights. Evidence shows that biological insights have 
been encoded in network properties . Therefore, network property analysis of integrated 
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networks (i.e., signaling networks incorporated with cancer related high-throughput -omic 
data) will provide new biological insights. 
The core concepts of network analysis are non-linear and network perspectives. 
Emergent biological properties may be discovered from non-linear thinking. The results of 
linear thinking are often predictable and expected, whereas the results of network analyses 
are often non-linear and unexpected. In theory, network analysis could lead to more 
unexpected and, therefore, exciting results. 
Network properties range from local (i.e., single node or edge, network bottlenecks, 
network motifs and modules) to global or network-wide (i.e., whether all nodes are 
connected, network diameter, shortest path, density, average links, clustering coefficient, 
network centrality, degree centrality, closeness centrality, radiality, betweenness and 
pageRank, minimum spanning trees, and network flows). A detailed survey of network 
measurements and properties has been described by Costa et al. (http://arxiv.org/abs/cond-
mat/0505185). Intrinsic relationships exist between local and global properties, such that 
sometimes a perturbation of a small number of linked nodes can result in widespread 
consequences. For example, a collection of protein network modules with gene co-
expression alterations leads to breast cancer metastasis . Further details about network 
biology concepts such as graph theory, network measurements and analysis are described 
in Chapters 2 and 4. The terms and concepts in Chapters 2 and 4 will be used in the 
following examples to illustrate network analysis in cancer biology.
Based on the specific questions being addressed, different methods of network 
analysis can be applied. The architectural structure of cellular networks provides a 
framework to illustrate the logics and mechanisms of cancer biology. Regarding global 
network features, for example, the following cancer biology questions could be addressed: 
extracting a subnetwork of cancer signaling that reflects functionality of cancer 
development or metastasis; uncovering the mechanisms by which genetic and epigenetic 
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events affect cancer cell signaling and tumor progression; identifying central players (i.e., 
network hubs that are cancer genes) in cancer cellular networks; identifying subnetworks 
that are functionally targeted cancer hallmarks, such as cell cycle and apoptosis. These 
analyses allow for the narrowing down of the scale of these complex networks. Further, 
they capture the communications between the core molecular processes in cancer and 
uncover the molecular mechanisms responsible. 
Many questions can also be addressed using local network features. For example, 
the enrichment of cancer driver-mutating genes (oncogenes) in positive feedback signaling 
loops (network motifs) suggests that oncogenes gain function due to mutation, whereas the 
enrichment of cancer methylated genes in negative regulatory signaling loops suggests that 
loss of function by gene methylation promotes tumorgenesis . The cancer signaling 
network, extracted from the human signaling network by integrating cancer driver mutated 
genes and cancer methylated genes, has been decomposed into 12 modules (network 
modules or communities). Furthermore, high-order collaborative relationships between 
these modules have been identified in different types of cancers . 
Although cancer is considered a very heterogeneous disease, querying mutated 
genes in tumor samples using the network modules defined by a human cancer signaling 
map reveals that one common network module occurs in most tumor samples. Specifically, 
breast and lung cancers show more complex collaborative patterns of oncogenic signaling 
modules than the other cancer types examined, highlighting their heterogeneous nature . 
These examples demonstrate that network biology is a powerful tool that elegantly 
provides new insights into biology. Moreover, most of these insights cannot be drawn from 
traditional biological approaches, which are dominated by linear thinking. 
Network analysis also provides a powerful tool for generating testable hypotheses. 
For example, Fu et al. found that ubiquitin-mediated proteins are enriched in positive loops 
in the human signaling network. Gene Ontology enrichment analysis of the ubiquitin-
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mediated proteins in these positive loops suggests that the biological process apoptosis is 
enriched in this group of proteins. Furthermore, more than 85% of the ubiquitin-mediated-
apoptotic proteins in these positive loops are cancer-associated genes. These observations 
led to the hypothesis that the ubiquitination machinery, such as the 26S, could be more 
highly expressed in tumor cells than in normal cells (high expression of ubiquitination 
machinery genes will block apoptosis, an essential block in cancer signaling). Using 
microarray data from both tumor and normal samples, Fu et al. provide evidence that this 
hypothesis is true . More examples of cancer network analyses are discussed extensively in 
Chapters 4-7.
 
2.4.3 Network Dynamics Analysis and Gene Markers for Diagnosis and Prognosis  
Genetic variation and somatic mutations in human populations, and even in tumor samples 
from the same individual, make tumors a very heterogeneous tissue type. The 
heterogeneous nature of tumors leads to different responses from different patients with the 
same type of cancer to treatment with the same drug. To address this problem, personalized 
medicine proposes to identify molecular markers for drug responses. 
Another issue in cancer treatment is how to predict which patients with cancer 
should receive extra therapy after surgery. Currently, most cancer patients undergo 
surgery. If physicians know which patients are in the earliest stages of cancer, they could 
better predict which patients might benefit from additional treatment. However, physicians 
cannot predict which patients with cancer should receive extra therapy after surgery. At 
present, it is very difficult to predict which patients will be cured by surgery alone, the 
single treatment most patients receive, and which patients might benefit from the addition 
of chemotherapy. Therefore, it is critical to identify those genes that can be used as tools to 
predict survival after diagnosis of cancer and those genes that can guide how oncologists 
should treat the cancer to obtain the best outcome. 
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Practically, we are facing the challenge of identifying robust and highly accurate 
molecular markers for drug response and survival prediction (prognosis). Enormous efforts 
have been made for more than 10 years to identify such biomarkers from gene microarray 
profiles. In fact, PubMed contains more than 3,000 publications on this subject. However, 
no robust biomarkers have yet been identified for cancer. Specifically, the current so-called 
breast cancer biomarkers are ineffective when used in a different set of breast tumor samples.
It is expected that the use of a systems approach could extract more accurate and 
mechanism-based markers of patient response to drug treatment by capturing the system 
dynamics. This approach requires integration of cellular networks and the alterations of 
gene expression, genetic mutation, methylation, and protein modifications with clinical 
information such as drug response, patient outcomes, etc. These efforts will fundamentally 
change both the health care system and the management strategies for cancer patients. 
Two recent studies demonstrated that the network biology approach offers 
promising results toward finding better markers for cancer prognosis. Mapping tumor-
expressed genes onto a human protein interaction network allows for the identification of 
subnetworks as cancer biomarkers. The resulting subnetwork markers are more 
reproducible than individual marker genes, which are selected without protein interaction 
information. These subnetwork markers also achieve higher accuracy in classification of 
metastatic versus non-metastatic tumors . Alteration of the co-expression of genes that are 
organized as protein network modules is associated with cancer metastasis, suggesting that 
dynamic rewiring of protein interaction modules is implicated in metastasis. Based on this 
discovery, network module markers have been shown to reach higher survival prediction 
for breast cancer patients than other markers selected from gene clustering, an approach 
that does not consider genes as interacting modules . We hope that network biology 
approaches will be applied to the discovery of drug response markers in the future.           
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2.5 Dynamic Network Modeling
Biology is currently experiencing a high level of interest in developing an understanding of 
system dynamics, specifically in studying systems made up of communicating parts and 
machines, information processing (cell signaling), and interconnected computational and 
functional units. In this perspective, organisms are viewed as information manipulators and 
processors.  
Network modeling uses methods from dynamical systems theory to model and 
simulate networks to decode the information processing machines and test hypotheses 
about the mechanisms that underlie the function of cancer cells. In network modeling, the 
behavior of cancer cells is represented in terms of quantitative changes in the levels of gene 
transcripts or enzyme activities (i.e., kinase activity). 
Network modeling provides conceptual and computational tools with which to 
perform and iterate dry-lab experiments. Network modeling enables simulation-based 
research within a quantitative reference framework that connects in silico replica and real 
systems by means of quantitative conceptual and computational tools. In the long term, 
network modeling approaches could replace many time intensive or expensive wet-lab 
experiments. In this context, the growing field of systems biology is expected to lead to 
fundamental breakthroughs in cancer biology. 
Two basic approaches (qualitative and quantitative) to dynamic network modeling 
are often used. Qualitative network modeling considers the states (i.e., gene expression 
values, protein concentrations, active, or non-active) of the network nodes in a finite 
number of values (i.e., ON and OFF, higher or lower than threshold, etc), whereas 
quantitative network modeling considers the states of nodes over a wide range of values. In 
addition, quantitative modeling also considers probabilistic, deterministic or stochastic 
characteristics of the network.
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Dynamic network models are composed of three basic elements: the cellular 
network (i.e., networks of gene regulation, protein interaction or signaling in a given 
cellular context), the initial state of each node, and the transfer functions that describe the 
state dependencies of each node in terms of its regulators. Node states can be modeled in 
either a continuous or a discrete manner, whereas the transfer functions can be modeled in 
either a deterministic or a stochastic fashion. Therefore, there are four methods (continuous 
deterministic model, continuous stochastic model, discrete deterministic models and 
discrete stochastic model) for dynamic network modeling. A discrete state approach may 
‘precisely’ describe the system's behavior, whereas continuous state equations describe the 
"average behavior" of the system 
In theory, a continuous stochastic model describes the system more accurately and 
more closely reflects the real system. However, high quality experimental data are required 
to apply this modeling method. The limited availability of high quality quantitative data 
forms a major bottleneck for the application of continuous stochastic models. Compared 
with the continuous stochastic model, a continuous deterministic model describes the 
system without taking into account the stochastic (noise) nature of the system. A discrete 
stochastic model usually accounts for noise in the transfer functions (differential equations) 
and models the nodes with two or a few states. 
 A discrete deterministic model has a high level of abstraction of node states (i.e., 
node states are assigned into only a few categories, even two binary states such as ON and 
OFF). The transfer functions are encoded as logic functions, such as "and," "or," and "not". 
Boolean models are one representative group of the discrete deterministic modeling 
method. This method requires relatively little detailed input information. Therefore, this 
method is more attractive and feasible, because the data generated from current 
experimental systems are suitable for this modeling method. One of the disadvantages of 
this method is that the predictions are generally more macro-scale and less quantitative. 
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A comprehensive survey of the methods and computational tools for dynamic 
network modeling can be found in Chapter 16. An application of Boolean models to cancer 
cell death signaling networks has been documented in Chapter 8. Other modeling examples 
can be found in Chapters 9-11.  
In summary, systems biology is leading to fundamental changes in cancer biology. 
In terms of dynamic network modeling, high quality quantitative data (i.e., quantitative 
proteomic data for signaling networks) are still requoired. Current methods for producing 
high quality data for modeling are still expensive and time consuming. Development of 
new methods for network analysis and modeling are also needed. Most importantly, more 
scientific investigators need to be trained to think in a network fashion, rather than in a 
traditional linear fashion.   
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